Designing Risk‑Based Facilities for Ancillary Material Manufacturing in Regulated Biopharmaceutical Environments
Ancillary materials sit behind the scenes of every cell and gene therapy—but they can introduce significant regulatory and contamination risk. Learn how risk-based facility design and robust quality systems can help ensure safe, compliant manufacturing.
White Papers
Mar 09, 2026
